Drug Profile
Budesonide suppository - Dr Falk Pharma
Latest Information Update: 27 Sep 2022
Price :
$50
*
At a glance
- Originator Dr Falk Pharma
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antivirals; Glucocorticoids; Pregnenediones; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Ulcerative proctitis
Most Recent Events
- 27 Sep 2022 Discontinued - Phase-III for Ulcerative proctitis in Germany (Rectal)
- 27 Sep 2022 Discontinued - Phase-III for Ulcerative proctitis in Hungary (Rectal)
- 27 Sep 2022 Discontinued - Phase-III for Ulcerative proctitis in Latvia (Rectal)